Regencor Logo


Advancing regenerative
medicine Targeting Myocardial Infarction
& Heart Failure

Arrow pointing down


1 / 5


2 / 5


3 / 5


4 / 5


5 / 5

Our Vision

Myocardial Regeneration
The ultimate goal of clinical cardiology

Regencor's team envisions a future where myocardial infarctions no longer impose incurable & life threatening tissue damage or progression to heart failure

Regencor's Technology

Subcutaneous Sustained Delivery via Pump:
A true game-changer in heart disease therapy

Our recombinant protein, delivered subcutaneously, reverses the formation of scar tissue. Scar tissue is the most serious complication after a myocardial infarction as it weakens the heart and leads to progressive heart failure.


Thomas Okarma - Chairman, President & CEO of Regencor

Thomas Okarma, MD, PhD
Executive Chairman and Co-founder

Pilar Ruiz-Lozano - Chief Scientific Officer at Regencor

Pilar Ruiz-Lozano, PhD
Chief Scientific Officer

Mark Mercola - Director at Regencor

Sean Edward
President & CEO